Colorado med spa & injectable regulations

⚠️ the hormone-therapy trap. It is unprofessional conduct to dispense, inject or prescribe an anabolic steroid “for the purpose of the hormonal manipulation that is intended to increase muscle mass, strength, or weight without a medical necessity to DO so or for the intended purpose of improving performance in any form of exercise, sport, or game.” Medical necessity is the whole of the defense; a performance or physique rationale is the violation.

Colo. Rev. Stat. § 12-240-121(1)(o)

⚠️ and the adjacent ground is a felony. Dispensing or injecting an anabolic steroid is unprofessional conduct “unless the anabolic steroid is dispensed from a pharmacy prescription drug outlet pursuant to a prescription order or is dispensed by any practitioner in the course of the practitioner’s professional practice” — and any person who violates that provision commits a class 5 FELONY, with a second or subsequent violation A CLASS 3 FELONY. Sourcing outside a pharmacy is the exposure.

Colo. Rev. Stat. § 12-240-121(1)(p); § 12-240-135(3)

Practicing, or offering or attempting to practice, medicine without an active license carries penalties under § 12-20-407(1)(a). Separately, presenting another’s credentials as one’s own, giving false or forged evidence to the board, practicing medicine “under a false or assumed name”, or falsely impersonating another licensee is A CLASS 6 FELONY. Note that offering counts — the advertisement can be the act.

Colo. Rev. Stat. § 12-240-135(1)–(2)

⚠️ and the unlawful practitioner cannot sue for the fee. “no action may be maintained against an individual who has been the recipient of services constituting the unlawful practice of medicine … for the breach of a contract involving the unlawful practice of medicine… or the recovery of compensation for services rendered under such a contract.” A patient treated unlawfully owes nothing, and the debt is unenforceable.

Colo. Rev. Stat. § 12-240-135(4)

The board may apply, in accordance with section 12-20-406, for an injunction to enjoin any person from committing any act prohibited by article 240, the Medical Practice Act; and any person who practices or offers or attempts to practice medicine within the state without an active license issued under article 240 is subject to penalties pursuant to section 12-20-407(1)(a).

Colo. Rev. Stat. § 12-240-135(1), (7)

⚠️ who may compound or dispense at all, which is the first gate on a compounded glp-1. “only a registered prescription drug outlet or other outlet registered pursuant to section 12-280-119 (1)(d) may compound or dispense a prescription.” a med spa is not a prescription drug outlet, so the default position is that it may do neither.

Colo. Rev. Stat. § 12-280-120(4)

⚠️ and the exception that matters is personal. “a practitioner may personally compound and dispense for any patient under the practitioner’s care any drug that the practitioner is authorized to prescribe and that the practitioner deems desirable or necessary in the treatment of any condition being treated by the practitioner, and the practitioner is exempt from all provisions of this article 280 except section 12-280-129.” Two words carry the weight: PERSONALLY, and under the practitioner’s care. This is not a route for staff to compound, nor for stock held against future demand.

Colo. Rev. Stat. § 12-280-120(6)(a)

What still binds the personally-compounding practitioner is § 12-280-129, the unlawful-acts section named in that exemption. It is unlawful “to sell, compound, dispense, give, receive, or possess any drug or device unless it was sold, compounded, dispensed, given, or received in accordance with sections 12-280-120 TO 12-280-125”, and unlawful “to dispense any drug without complying with the labeling, drug identification, and container requirements imposed by law”. The exemption removes the registration machinery, not the conduct rules.

Colo. Rev. Stat. § 12-280-129(1)(g), (1)(l)

⚠️ Colorado wrote an office-stock compounding route and confined it to animals. § 12-280-121 lets a registered prescription drug outlet “compound and distribute a drug to a licensed veterinarian so that the veterinarian may maintain the drug as part of the veterinarian’s office stock” — and only for an animal patient’s EMERGENCY condition, capped at the amount needed for FIVE DAYS, with a valid veterinarian-client-patient relationship in place. A pharmacy’s veterinary compounding may not exceed ten percent of its annual dosage units. That a legislature built this route, and built it only for veterinarians, is the strongest signal in Colorado law about human office stock.

Colo. Rev. Stat. § 12-280-121; § 12-280-120(6)(b)

⚠️ the lawful route to compounded stock is the 503b outsourcing facility, and Colorado defines it by that very feature. a “nonresident 503B outsourcing facility” is one registered by the FDA, located outside the state, “that distributes compounded drugs into the state without a prescription order”; a resident one distributes compounded drugs within the state. Distribution without a patient-specific prescription is what separates this channel from a pharmacy — and the board may inspect a nonresident facility after a risk-based assessment.

Colo. Rev. Stat. § 12-280-103(28.5), (46.5)

⚠️ there is no med spa registration, license or facility permit, and no medical director is required. Article 240 — the Colorado Medical Practice Act — was surveyed in full for this entry and creates no facility license, registration, permit or fee for a cosmetic practice. Its ONLY use of the phrase “medical director” is an exemption from licensure for a person “practicing as a medical director pursuant to the ‘recognition of emergency medical services personnel licensure interstate compact act’” — an EMS role, not a cosmetic one. The wider Title 12 never uses the phrase “medical spa” at all. Colorado is the opposite of Tennessee, which registers the facility, charges $175 and requires a named medical director to sign for it. The Colorado gate is the professional service corporation and the individual license behind it.

Colo. Rev. Stat. art. 240 of tit. 12, surveyed in full; the sole medical-director reference is § 12-240-107(3)(y)

The provision that reaches an unlicensed OWNER rather than the practitioner is the deemed-practice rule: if a person who does not hold and has not filed a license, and who is not exempt, “performs any of the acts that constitute the practice of medicine as defined in this section, the person shall be deemed to be practicing medicine … in violation of this article 240.” Maintaining “an office or other place for the purpose of examining or treating persons” is itself one of those acts.

Colo. Rev. Stat. § 12-240-107(1)(c), (2)

⚠️ Colorado fixes no fee amount in statute — its fees float to cover the regulator’s costs. Section 12-20-105 applies “to all activities of the division and all regulators”, and the mechanism is annual: “The director shall propose, as part of the division’s annual budget request, an adjustment in the amount of each fee that each regulator is authorized by law to collect”, and then “each regulator shall adjust the fees the regulator is authorized by law to collect so that the revenue generated from the fees approximates its direct and indirect costs.” A Colorado operator therefore has no statutory figure to plan against, and the number can move every budget year.

Colo. Rev. Stat. § 12-20-105(1), (2)(a), (2)(b)(I)

Colorado's Board of Pharmacy rules set out an application to the Board for outsourcing facilities located outside the state: “A nonresident 503B outsourcing facility shall submit the following to the Board with the application: a. Proof that the facility is actively registered with the Federal Food and Drug Administration as a 503B outsourcing facility and is actively licensed, permitted, or registered in the state in which it is a resident”. The same rule also requires the facility to provide the location, names, and titles of its principal entity officers and the name of the pharmacist in charge, verification that it complies with FDA and home-state regulator directions and with Board requests for information, and a copy of its most recent FDA inspection report.

3 Colo. Code Regs. § 719-1, Rule 5.00.17